Expand XPH Menu
XPH MENU

XPH ETF Profile


Family: State Street (SPDR)
Name: SPDR S&P Pharmaceuticals ETF
Inception Date: 19-Jun-2006
Termination Date:
Investment Objective: The SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the Index ).The S&P Pharmaceuticals Select Industry Index (the Index ) represents the pharmaceuticals segment of the S&P Total Market Index ( S&P TMI ). The S&P TMI is designed to track the broad U.S. equity market. The pharmaceuticals segment of the S&P TMI comprises the Pharmaceuticals sub-industry. The Index is one of twenty-one (21) of the S&P Select Industry Indices (the Select Industry Indices ), each designed to measure the performance of a narrow sub-industry or group of sub-industries determined based on the Global Industry Classification Standard ( GICS ).
Prospectus
Top 10 Holdings
ORGANON + CO OGN 2.5938%
ENLIVEN THERAPEUTICS INC ELVN 2.5803%
CORCEPT THERAPEUTICS INC CORT 2.3452%
TREVI THERAPEUTICS INC TRVI 2.1542%
DEFINIUM THERAPEUTICS INC DFTX 2.1430%
PERRIGO CO PLC PRGO 2.0964%
AXSOME THERAPEUTICS INC AXSM 2.0814%
AMYLYX PHARMACEUTICALS INC AMLX 2.0668%
NEKTAR THERAPEUTICS NKTR 2.0456%
TERNS PHARMACEUTICALS INC TERN 2.0309%
Top 10 Holdings Weight: 22.1%
Number of Holdings: 61
Shares Outstanding: 6,100,270
Total Net Assets: 350,765,500
NAV: 57.46
Net Expense Ratio: 0.35%
Asset Class: Equities (Stocks)
Developed or Emerging: Developed Market Funds
Country: US
Region:
Strategy:
Currency:
Commodity:
Sector: Healthcare
Industry: Pharmaceuticals
Dividend Type:
Tax Exempt State:
Maturity Duration:
Market Cap: Broad Market / Multi-Cap
Credit Quality:
Mortgage Bond Types:
Bond Type:
Gov't Bond Types:
Reit Type:
Leverage Direction/Factor:
Is Currency Hedged: No
US or Ex-US: Domestic
Market Data Delayed 15 Minutes